Regulatory Strategy

05 May
14:00 - 15:30

Health2B
Oslo Science Park
(or digitally)

What defines a product as medical technology? What does it entail to be a medical device? Get an introduction to how to plan your regulatory strategy.

We have invited Caterina Håland Gaeta from SANDS who is a lawyer with long experience and knowledge in advising companies on their regulatory strategy for medical device. She will be joined by Ingrid Langmoen Juel from Inventas who will share experience and cases from their customers.

Jonas Jeppesen and Arnar Kristiansson from Zyberia will talk about where they are now and the strategy they have going forward towards regulatory approval.

We will wrap things up with a discussion and Q&A session, led by Anita Moe Larsen from Norway Health Tech. Everyone is welcomed by project leader for Vekst i Viken, Kari Anne Dehli (Norway Health Tech).

Please join us! Either in Oslo Science Park or digitally.

This meeting will be in Norwegian

This is a part of Vekst in Viken, funded by:

 

 

Register

Speakers

Caterina Håland Gaeta

Partner - SANDS

cga@sands.no

Ingrid Juel Langmoen

Prosjekteier - Inventas Oslo

ingrid.langmoen@inventas.no

Jonas C. Jeppesen

Advisor Innovation Projects - Norway Health Tech

jcj@zyberia.no

Dr. ing Arnar Kristjansson

Partner - Xybel AS

arnar.kristjansson@xybel.com

Kari Anne Dehli

Senior Project leader - Norway Health Tech

kad@norwayhealthtech.com

Anita Moe Larsen

Head of Communication - Norway Health Tech

aml@norwayhealthtech.com